Published in Obesity and Diabetes Week, March 10th, 2003
"We investigated whether serum levels of N-(carboxymethyl)lysine (CML), non-CML advanced glycation endproducts (AGEs), or pentosidine are associated with severity of diabetic microvascular complications in patients with type I diabetes," researchers in Japan reported.
"Serum levels of CML, non-CML AGE, and pentosidine were measured by an enzyme-linked immunosorbent assay in 38 males, and 47 females aged 31±8 years (mean±S.D.) with type 1 diabetes for 18.7±7.0 years," said J. Miura and colleagues, Tokyo Women's Medical University, School of Medicine.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.